Tharimmune Stock (NASDAQ: THAR) stock price, news, charts, stock research, profile.
You can purchase shares of Tharimmune (NASDAQ:THAR) through any online brokerage.
Other companies in Tharimmune’s space includes: Vincerx Pharma (NASDAQ:VINC), Synaptogenix (NASDAQ:SNPX), Quoin Pharmaceuticals (NASDAQ:QNRX), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Palisade Bio (NASDAQ:PALI).
Tharimmune has a consensus price target of $17.00.
The stock price for Tharimmune (NASDAQ: THAR) is $1.9 last updated February 13, 2025 at 3:58 PM EST.
There are no upcoming dividends for Tharimmune.
Tharimmune’s Q4 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for Tharimmune.
Tharimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.